Azintuxizumab vedotin

DB14847Investigational

Azintuxizumab vedotin is under investigation in clinical trial NCT02951117 (A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or...

Mechanism: Pharmacologically active on SLAM family member 7
Curator reviewed
Code names: ABBV-838

Resolves to

Compound

UNII6XQ9TM3U2GCAS1826819-58-2

Targets

Q9NQ25SLAMF7

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Azintuxizumab vedotin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account